Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Neoplasms × Phlebotomy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Polycythemia Vera 4 Lung Neoplasms 4 Myeloproliferative Disorders 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Lymphoma 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Squamous Cell 2 Brain Neoplasms 2 Adenocarcinoma 2 Urticaria 1 Tuberous Sclerosis 1 Thymic aplasia 1 Thrombosis 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Small Cell Lung Carcinoma 1 Severe Combined Immunodeficiency 1 Sarcoma 1 Salivary Gland Neoplasms 1 Renal Insufficiency, Chronic 1 Rectal Neoplasms 1 Primary Dysautonomias 1 Polycythemia 1 Polycystic Ovary Syndrome 1 Pancreatitis, Chronic 1 Pancreatitis 1 Pancreatic Cyst 1

Interventions

Carboplatin 274 Paclitaxel 273 Bevacizumab 148 liposomal doxorubicin 86 pembrolizumab 84 Gemcitabine 82 Cyclophosphamide 81 olaparib 79 Cisplatin 75 Topotecan 72 niraparib 59 Docetaxel 49 Doxorubicin 44 Drug Therapy 38 fludarabine 35 Taxes 35 Nivolumab 32 Filgrastim 31 Specimen Handling 29 Etoposide 28 Surveys and Questionnaires 27 Magnetic Resonance Spectroscopy 27 Hyperthermic Intraperitoneal Chemotherapy 27 Peripheral Blood Stem Cell Transplantation 23 durvalumab 21 Immunoglobulin G 21 Disulfides 21 Cytoreduction Surgical Procedures 21 Blood Specimen Collection 21 Biopsy 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02781272 2023-06-05

EMBER

Angle plc

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡